The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS): A multicenter study.
 
Aisha Alshibany
No Relationships to Disclose
 
Maggie Zhou
No Relationships to Disclose
 
Emilie AK Warren
No Relationships to Disclose
 
Kristen N. Ganjoo
Consulting or Advisory Role - Adaptimmune; Boehringer Ingelheim; Boehringer Ingelheim; Deciphera; Foundation Medicine
 
Elizabeth Demicco
Patents, Royalties, Other Intellectual Property - Authorship Royalties, from UpToDate (Wolters Kluwer), Chapter: "Solitary fibrous tumors"
 
Jordan Feeney
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Jasmine Lee
No Relationships to Disclose
 
David Benjamin Shultz
No Relationships to Disclose
 
Erik Spickard
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Nam Bui
Consulting or Advisory Role - Rain Therapeutics; SpringWorks Therapeutics
 
Kenneth Cardona
No Relationships to Disclose
 
Abdulazeez Salawu
Honoraria - Bayer; Medison
Consulting or Advisory Role - Boehringer Ingelheim; Knight Therapeutics; Taiho Pharmaceutical
 
Albiruni Ryan Abdul Razak
Consulting or Advisory Role - Adaptimmune; GlaxoSmithKline; Inhibrx; Medison
Research Funding - 23 and Me; Abbvie; Adaptimmune; Amgen; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Deciphera; Frontier Therapeutics; GlaxoSmithKline; Iterion Therapeutics; Karyopharm Therapeutics; MedImmune; Merck; Neoleukin Therapeutics; Pfizer; Rain Therapeutics; Roche/Genentech; Symphogen
Expert Testimony - Medison